Ikarian Capital’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.96M | Sell |
196,536
-288,485
| -59% | -$11.7M | 1.53% | 11 |
|
|
2025
Q1 | $24.9M | Sell |
485,021
-122,668
| -20% | -$6.3M | 3.07% | 1 |
|
|
2024
Q4 | $33.6M | Sell |
607,689
-422,588
| -41% | -$23.4M | 4.58% | 1 |
|
|
2024
Q3 | $33.9M | Buy |
1,030,277
+230,000
| +29% | +$7.56M | 4.73% | 1 |
|
|
2024
Q2 | $21.8M | Buy |
800,277
+90,000
| +13% | +$2.45M | 3.79% | 3 |
|
|
2024
Q1 | $25.8M | Buy |
710,277
+191,758
| +37% | +$6.97M | 2.83% | 2 |
|
|
2023
Q4 | $10.5M | Hold |
518,519
| – | – | 0.98% | 12 |
|
|
2023
Q3 | $9.21M | Buy |
+518,519
| New | +$9.21M | 1.11% | 9 |
|